Adenovirus for AZ vaccine, Sinopharm uses inactivated virus
By Lee, Tak-Sun | translator Byun Kyung A
21.01.07 10:23:08
가나다라
0
MFDS breaks down COVID-19 vaccine types and mechanisms
RNA and virus vector products already approved, recombinant and DNA vaccines still in development
Diverse types of COVID-19 vaccines are currently in development. Pfizer and Moderna’s vaccine candidates are based on RNA, when AstraZeneca’s is a virus vector and Korean-based SK Bioscience’ is a recombinant vaccine.
These types of vaccine have their respective strengths and weaknesses. Some types have been commercialized already, but mRNA vaccine has never been commercialized, making the COVID-19 vaccine the first product.
On Jan. 7, South Korea’s Ministry of Food and Drug Safety (MFDS) explained about the different types of COVID-19 in development and their mechanisms.
The international effort to promptly seek COVID-19 vaccine has pushed pharmaceutical companies to
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)